Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies

Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies

US Patent 9335320 · Granted May 10, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD3 antibodies and methods of use2025
ILT-binding agents and methods of use thereof2025
Immunomodulatory polypeptides and related compositions and methods2025
ILT-binding agents and methods of use thereof2023
Anti-CD3 antibodies and methods of use2023
Anti-CD3 antibodies and methods of use2022
Anti-CLL-1 antibodies and methods of use2022
Anti-FCRH5 antibodies2022
Anti-CD3 antibodies and methods of use2021
HPV-specific binding molecules2021
Anti-CD79b antibodies and methods of use2021
Anti-CD3 antibodies and methods of use2020